Global Pet Vaccine Market Research Report 2017

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 118246

In this report, the global Pet Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pet Vaccine in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Pet Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Pet Vaccine for each application, including
Canine
Avian
Feline

Table of Contents

Global Pet Vaccine Market Research Report 2017
1 Pet Vaccine Market Overview
1.1 Product Overview and Scope of Pet Vaccine
1.2 Pet Vaccine Segment by Type (Product Category)
1.2.1 Global Pet Vaccine Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Pet Vaccine Production Market Share by Type (Product Category) in 2016
1.2.3 Attenuated Live Vaccines
1.2.4 Conjugate Vaccines
1.2.5 Inactivated Vaccines
1.2.6 Subunit Vaccines
1.2.7 Toxoid Vaccines
1.2.8 DNA Vaccines
1.2.9 Recombinant Vaccines
1.3 Global Pet Vaccine Segment by Application
1.3.1 Pet Vaccine Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Global Pet Vaccine Market by Region (2012-2022)
1.4.1 Global Pet Vaccine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Pet Vaccine (2012-2022)
1.5.1 Global Pet Vaccine Revenue Status and Outlook (2012-2022)
1.5.2 Global Pet Vaccine Capacity, Production Status and Outlook (2012-2022)

2 Global Pet Vaccine Market Competition by Manufacturers
2.1 Global Pet Vaccine Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Pet Vaccine Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Pet Vaccine Production and Share by Manufacturers (2012-2017)
2.2 Global Pet Vaccine Revenue and Share by Manufacturers (2012-2017)
2.3 Global Pet Vaccine Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Pet Vaccine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Pet Vaccine Market Competitive Situation and Trends
2.5.1 Pet Vaccine Market Concentration Rate
2.5.2 Pet Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Pet Vaccine Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Pet Vaccine Capacity and Market Share by Region (2012-2017)
3.2 Global Pet Vaccine Production and Market Share by Region (2012-2017)
3.3 Global Pet Vaccine Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Pet Vaccine Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Pet Vaccine Consumption by Region (2012-2017)
4.2 North America Pet Vaccine Production, Consumption, Export, Import (2012-2017)
4.3 Europe Pet Vaccine Production, Consumption, Export, Import (2012-2017)
4.4 China Pet Vaccine Production, Consumption, Export, Import (2012-2017)
4.5 Japan Pet Vaccine Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Pet Vaccine Production, Consumption, Export, Import (2012-2017)
4.7 India Pet Vaccine Production, Consumption, Export, Import (2012-2017)

5 Global Pet Vaccine Production, Revenue (Value), Price Trend by Type
5.1 Global Pet Vaccine Production and Market Share by Type (2012-2017)
5.2 Global Pet Vaccine Revenue and Market Share by Type (2012-2017)
5.3 Global Pet Vaccine Price by Type (2012-2017)
5.4 Global Pet Vaccine Production Growth by Type (2012-2017)

6 Global Pet Vaccine Market Analysis by Application
6.1 Global Pet Vaccine Consumption and Market Share by Application (2012-2017)
6.2 Global Pet Vaccine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Pet Vaccine Manufacturers Profiles/Analysis
7.1 Bayer Healthcare
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Pet Vaccine Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bayer Healthcare Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Vetoquinol S.A
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Pet Vaccine Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Vetoquinol S.A Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Pet Vaccine Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Boehringer Ingelheim Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Ceva
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Pet Vaccine Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Ceva Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Eli Lilly
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Pet Vaccine Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Eli Lilly Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Heska Co.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Pet Vaccine Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Heska Co. Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Merck Animal Health
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Pet Vaccine Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Merck Animal Health Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Merial (Sanofi)
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Pet Vaccine Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Merial (Sanofi) Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Virbac
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Pet Vaccine Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Virbac Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Zoetis (Pfizer)
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Pet Vaccine Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Zoetis (Pfizer) Pet Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview

8 Pet Vaccine Manufacturing Cost Analysis
8.1 Pet Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pet Vaccine

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pet Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pet Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Pet Vaccine Market Forecast (2017-2022)
12.1 Global Pet Vaccine Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Pet Vaccine Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Pet Vaccine Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Pet Vaccine Price and Trend Forecast (2017-2022)
12.2 Global Pet Vaccine Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Pet Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Pet Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Pet Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Pet Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Pet Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Pet Vaccine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Pet Vaccine Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Pet Vaccine Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer